Navigation Links
Hand Washing with 4% CHG Antiseptic Kills Flu Viruses
Date:6/24/2009

Study shows 4% CHG antiseptic is effective against a strain of H1N1 Swine Flu

NORCROSS, Ga., June 24 /PRNewswire/ -- Hand washing with a 4% chlorhexidine gluconate (CHG) antiseptic hand washing product is one effective way to stop the spread of the H1N1 Swine Flu Virus.

Hibiclens Antiseptic/Antimicrobial Skin Cleanser and Hibistat Healthcare Personnel Hand Antiseptic Towelettes have been tested and found to be effective against a variation of the A H1N1 Swine Flu Virus, when used according to package instructions. The strain tested was Swine Flu Influenza A H1N1 A/Swine/Iowa/15/3.

The time-kill study, conducted by an independent laboratory showed that Hibiclens(R), a 4% CHG product, reduced the virus by 99.94 percent after 30 second, 60 second, and three minute exposures. Hibistat(R), a 0.5% CHG and 70% isopropyl alcohol formulation, reduced the virus by 99.99 percent after 15 second, 30 second and 60 second exposures. Both Hibiclens and Hibistat were more effective than soap and water which was used as a comparator test product.

"With any type of influenza outbreak, managing the spread of virus is the biggest concern," said Carolyn Twomey, RN, Global Head of Clinical Services, Molnlycke Health Care. "Influenza viruses usually spread via sneezing and coughing and contaminating one's hand or hands, and then touching surfaces, shaking hands or other contact behaviors. With any influenza outbreak, good hand hygiene is extremely important. With the current strains of flu virus, this study shows that washing with Hibiclens or using Hibistat Hand Wipes provides additional benefit in preventing transmission."

"Use of Molnlycke Health Care's Hibiclens and Hibistat antimicrobial/antiseptic products, along with the company's line of surgical facemasks and respirators, can be an integral part of a protocol to reduce the risk of cross-contamination," Twomey said.

Hibiclens is an antimicrobial/antiseptic cleanser that kills germs on contact and bonds with the skin to keep killing microorganisms for up to six hours without leaving a residue. The same cleanser combined with alcohol is available in convenient Hibistat(R) towelettes. Both are available at drug stores and pharmacies in the first aid section. For more information about Hibiclens, Hibistat or CHG, visit www.hibigeebies.com.

About Molnlycke Health Care US, LLC

Molnlycke Health Care US, LLC, consists of two divisions - Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division (formerly Regent Medical Americas, LLC) encompasses the world's leading manufacturer and supplier of powder-free surgical gloves (Biogel(R) surgical gloves); the number one supplier (by value) of skin cleanser (Hibiclens(R) and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.


'/>"/>
SOURCE Molnlycke Health Care
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
2. Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro)
3. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
4. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
5. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
6. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
7. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
8. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
9. DuPont Provides Technology for Washington Hospital Centers Emergency Department
10. Top Washington Health Officials to Honor Framingham Heart Study Participants
11. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class ... support to bring their novel lifesaving device for the everyday use of parents ... sensors, specially designed to read a child’s vital signs, and detect unusual symptoms ...
(Date:4/24/2017)... Ill., and Waycross, Ga. (PRWEB) , ... April ... ... market leader and trusted advisor within the telehealth industry, announces the company’s VideoMedicine ... U.S. board-certified primary care providers. Available 24 hours a day, Quick Care provides ...
(Date:4/24/2017)... ... April 24, 2017 , ... According ... overdose deaths now claim the lives of 62 Americans each day.(1) Yet since ... drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... ... 2017 , ... Pitavastatin, a relatively new statin, has relevance ... to have significant interactions with antiretroviral therapy (ART). Among people living with ... inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation are beneficial ...
Breaking Medicine News(10 mins):